Brief: Quantum Genomics FY Net Loss Widens To 9.4 Million Euros
March 29 (Reuters) - QUANTUM GENOMICS SA ALQGC.PA :
* ON 31 DECEMBER 2017, OPERATING INCOME WAS -EUR10.3
MILLION,
COMPARED WITH -EUR6.2 MILLION ONE YEAR EARLIER
* AT END-DEC., THERE WAS €8.9 MILLION IN EQUITY CAPITAL AND
€11.1
MILLION IN AVAILABLE CASH FLOW
* FY NET LOSS EUR 9.4 MILLION VERSUS LOSS OF EUR 5.2
MILLION
YEAR AGO
* REPORTS FOR H1 A NET INCOME OF -EUR9.4 MILLION VERSUS
-EUR5.2
MILLION FOR FIRST HALF OF 2016
Source text for Eikon: ID:nACT52531
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study